[1] |
O'RIORDAN M N, HIGGINS J R. Haemostasis in normal and abnormal pregnancy[J]. Best Pract Res Clin Obstet Gynaecol, 2003, 17(3):385-396.
DOI
URL
|
[2] |
CERNECA F, RICCI G, SIMEONE R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state,combined with a reactive fibrinolysis[J]. Eur J Obstet Gynecol Reprod Biol, 1997, 73(1):31-36.
DOI
URL
|
[3] |
UCHIKOVA E H, LEDJEV I I. Changes in haemostasis during normal pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2005, 119(2):185-188.
PMID
|
[4] |
陈慧芬. 产科易栓症的检测在反复自然流产病因诊断中的临床价值[J]. 中华检验医学杂志, 2017, 40(11):856-859.
|
[5] |
谢幸, 孔北华, 段涛, 等. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018.
|
[6] |
KUPFERMINC M J, ELDOR A, STEINMAN N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy[J]. N Engl J Med, 1999, 340(1):9-13.
DOI
URL
|
[7] |
BREMME K, OSTLUND E, ALMQVIST I, et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium[J]. Obstet Gynecol, 1992, 80(1):132-137.
PMID
|
[8] |
WICKSTRÖM K, EDELSTAM G, LÖWBEER C H, et al. Reference intervals for plasma levels of fibronectin,von-Willebrand factor,free protein S,and antithrombin during third-trimester pregnancy[J]. Scand J Clin Lab Invest, 2004, 64(1):31-40.
DOI
URL
|
[9] |
LEFKOWITZ J B, CLARKE S H, BARBOUR L A. Comparison of protein S functional and antigenic assays in normal pregnancy[J]. Am J Obstet Gynecol, 1996, 175(<W>3 Pt 1):657-660.
DOI
URL
|
[10] |
ORUÇ S, SARUÇ M, KOYUNCU F M, et al. Changes in plasma activities of protein C and protein S during pregnancy[J]. Aust N Z J Obstet Gynaecol, 2000, 40(4):448-450.
DOI
URL
|
[11] |
SAID J M, IGNJATOVIC V, MONAGLE P T, et al. Altered reference ranges for protein C and protein S during early pregnancy:implications for the diagnosis of protein C and protein S deficiency during pregnancy[J]. Thromb Haemost, 2010, 103(5):984-988.
DOI
URL
|
[12] |
於王骐, 陈兆军, 袁园, 等. 健康妇女孕期抗凝指标的变化[J]. 中国卫生检验杂志, 2019, 29(9):1108-1110.
|
[13] |
NAKASHIMA A, KOBAYASHI T, TERAO T. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors[J]. Gynecol Obstet Invest, 1996, 42(2):95-101.
|
[14] |
COOLMAN M, DE GROOT C J, STEEGERS E A, et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally,during and after pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 128(1-2):22-28.
DOI
URL
|
[15] |
CHEN H, NIE S, LU M. Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss:a systematic review and meta-analysis[J]. Am J Reprod Immunol, 2015, 73(4):292-300.
DOI
URL
|